hassan arkaban

Dr. hassan arkaban

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 March 2022 in Polymers
Verified
Journal Article
Open access
PDF file
HAhassan arkaban
hassan arkaban
Mahmood BaraniMahmood Barani
Mahmood Barani
MAMajid Reza Akbarizadeh
Majid Reza Akbarizadeh
NCNarendra Pal Singh Chauhan
Narendra Pal Singh Chauhan
Sapana JadounSapana Jadoun
Sapana Jadoun
Payam ZarrintajPayam Zarrintaj
Payam Zarrintaj
Polyacrylic acid (PAA) is a non-toxic, biocompatible, and biodegradable polymer that gained lots of interest in recent years. PAA nano-derivatives can be obtained by chemical modification of carboxyl groups with superior chemical properties in comparison to unmodified PAA. For example, nano-particles produced from PAA derivatives can be used to deliver drugs due to their stability and biocompatibility. PAA and its nanoconjugates could also be regarded as stimuli-responsive platforms that make them ideal for drug delivery and antimicrobial applications. These properties make PAA a good candidate for conventional and novel drug carrier systems. Here, we started with synthesis approaches, structure characteristics, and other architectures of PAA nanoplatforms. Then, different conjugations of PAA/nanostructures and their potential in various fields of nanomedicine such as antimicrobial, anticancer, imaging, biosensor, and tissue engineering were discussed. Finally, biocompatibility and challenges of PAA nanoplatforms were highlighted. This review will provide fundamental knowledge and current information connected to the PAA nanoplatforms and their applications in biological fields for a broad audience of researchers, engineers, and newcomers. In this light, PAA nanoplatforms could have great potential for the research and development of new nano vaccines and nano drugs in the future.

12 May 2024 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
Sonia Fathi-karkanSonia Fathi-karkan
Sonia Fathi-karkan
NRNasim Amiri Ramsheh
Nasim Amiri Ramsheh
HAhassan arkaban
hassan arkaban
FNForoozan Narooie-Noori
Foroozan Narooie-Noori
SSSara Sargazi
Sara Sargazi
Mohammed Muzibur RahmanMohammed Muzibur Rahman
Mohammed Muzibur Rahman

14 January 2023 in Molecules
Verified
Journal Article
Open access
PDF file
MAMehdi Bazi Alahri
Mehdi Bazi Alahri
JAJibril I. S Alhawarin
Jibril I. S Alhawarin
Mahmood BaraniMahmood Barani
Mahmood Barani
HAhassan arkaban
hassan arkaban
SSSeyedeh Malahat Shadman
Seyedeh Malahat Shadman
Abduladheem Turki JalilAbduladheem Turki Jalil
Abduladheem Turki Jalil
The blood–brain barrier (BBB) serves as a protective barrier for the central nervous system (CNS) against drugs that enter the bloodstream. The BBB is a key clinical barrier in the treatment of CNS illnesses because it restricts drug entry into the brain. To bypass this barrier and release relevant drugs into the brain matrix, nanotechnology-based delivery systems have been developed. Given the unstable nature of NPs, an appropriate amount of a biocompatible polymer coating on NPs is thought to have a key role in reducing cellular cytotoxicity while also boosting stability. Human serum albumin (HSA), poly (lactic-co-glycolic acid) (PLGA), Polylactide (PLA), poly (alkyl cyanoacrylate) (PACA), gelatin, and chitosan are only a few of the significant polymers mentioned. In this review article, we categorized polymer-coated nanoparticles from basic to complex drug delivery systems and discussed their application as novel drug carriers to the brain.

8 March 2021 in Chromatographia
Verified
Journal Article
Closed access
PDF file
HAhassan arkaban
hassan arkaban
MMMohammad Mirzaei
Mohammad Mirzaei
MBMansoureh Behzadi
Mansoureh Behzadi